Abstract
On December 13, 2021, WHO and St Jude Children's Research Hospital jointly announced the launch of a new initiative to increase the supply of paediatric cancer medicines to low-income and middle-income countries (LMICs). The Global Platform for Access to Childhood Cancer Medicines will receive US$200 million in funding from St Jude Children's Research Hospital over the next 6 years. The platform aims to provide safe and effective cancer medication to approximately 120 000 children worldwide in 2022–27, with the expectation of a subsequent scale-up.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
